Novo Nordisk Ozempic discount at $199 boosts telehealth partnerships, increasing drug access and sales.
Browsing: Market Access
Updates on pricing, reimbursement, HTA decisions, and access policies affecting global healthcare markets.
HIV prevention drug distribution begins in Zambia and Eswatini with 1,000 doses, excluding South Africa.
Clinical trials access remains limited as only 24% of drugs tested in 89 countries are available post-approval.
Novo Nordisk Wegovy Pricing launches at $349 per month, months ahead of schedule, impacting the obesity drug market.
Ozempic pricing is under scrutiny as Senator Sanders suggests generic versions could cost under $100/month.
AmgenNow platform enhances direct-to-consumer access, aiming to streamline patient engagement and improve market reach.
Colorado Enbrel payment limit set at $600 per unit, impacting Amgen’s pricing strategy and potentially influencing other states.
Amgen Repatha pricing sees a 60% reduction in the U.S. through a new program, enhancing market access.
Keytruda subcutaneous launch by Merck aims to offset sales decline as original loses patent protection, with analysts projecting market impact.
Crystalys gout drug debuts with $205M funding and partial rights in multiple Asian countries.